All In Biotech

Free tool

FAERS Monitor: Trileptal

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021285 or its brand name (Trileptal, Oxcarbazepine). Reports on generic versions are filed under their own applications.

Reports

31,740

Serious

24,137

76% of reports

Hospitalization

9,889

Death reported

2,192

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective2,931
  • seizure2,829
  • off label use1,726
  • dizziness1,533
  • fatigue1,465
  • convulsion1,455
  • nausea1,317
  • headache1,301
  • somnolence1,251
  • fall1,208
  • hyponatraemia1,183
  • vomiting1,131
  • drug interaction1,055
  • rash1,003
  • depression951

Reports by year received

View as table
YearReports
2004631
2005749
2006782
2007779
2008722
20091,057
20101,058
20111,110
20121,389
20131,153
20141,247
20151,809
20161,930
20171,761
20181,893
20191,919
20201,795
20211,803
20221,644
20231,758
20241,747
20251,711
20261,290

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,022,419 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
convulsionSignal1,45517.316.421,785
seizureSignal2,82916.616.040,700
hyponatraemiaSignal1,18314.213.414,233
drug interactionSignal1,0554.44.22,800
somnolenceSignal1,2514.13.92,982
depressionSignal9512.82.61,087
fallSignal1,2082.42.31,008
dizzinessSignal1,5332.01.9829
vomiting1,1311.61.5256
rash1,0031.51.4185
drug ineffective2,9311.51.4476
headache1,3011.41.3137
off label use1,7261.31.2129
fatigue1,4651.21.274
nausea1,3171.11.013

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.